Genitourinary Radiology: Page 67

Trial results bolster hormone therapy plus radiation for prostate cancer
By AuntMinnie.com staff writers
When battling prostate cancer, how much firepower does androgen deprivation therapy (ADT) provide when paired with radiation therapy? Dr. Howard Sandler of the University of Michigan Medical Center in Ann Arbor took on the question by laying out the clinical evidence in favor of hormone therapy and radiation therapy.
March 30, 2008
PLC Systems inks Italian distribution pact
By AuntMinnie.com staff writers
PLC Systems of Franklin, MA, has signed an exclusive three-year agreement with Artech of Cavezzo, Italy, to distribute PLC's RenalGuard system in that country.
March 27, 2008
PLC to enroll patients in CIN study
By AuntMinnie.com staff writers
PLC Systems of Franklin, MA, has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin enrollment in a trial to study its RenalGuard product for preventing contrast-induced nephropathy (CIN).
March 20, 2008
HealthTronics to acquire urological cryosurgery services provider
By AuntMinnie.com staff writers
Healthcare firm HealthTronics has brokered a deal to acquire Advanced Medical Partners (AMPI), a urological cryosurgery services company, the firm reported.
March 19, 2008
Cook begins Reform clinical trial
By AuntMinnie.com staff writers
Interventional technology firm Cook Medical has launched the Reform clinical trial, designed to evaluate its Formula balloon expandable stent for treating renal artery stenosis.
March 19, 2008
Targeted renal therapy offers a solution to contrast allergic reactions
By Micheal Casasnovas
Radiologists aren't the only ones who must grapple with contrast-induced allergic reactions: Endovascular therapy specialists may see their choices for imaging exams limited by issues such as contrast-induced nephropathy and hypersensitivity to gadolinium, according to an imaging expert from Columbia University. But the use of targeted renal therapy may reduce the incidence of contrast-induced nephropathy.
February 18, 2008
Microbubble contrast shows broad potential for US
By Eric Barnes
A laboratory at the University of California, Davis, is finding new ways to harness ultrasound for the exploration of disease processes, aiming to move its experimental models into clinical practice as rapidly as possible. Heading the effort is Katherine Ferrara, Ph.D., a researcher with great faith in tiny bubbles.
February 11, 2008
2008 02 11 14 50 46 706
NuView, Thomas Jefferson to collaborate
By AuntMinnie.com staff writers
NuView Radiopharmaceuticals of Park City, UT, has entered an agreement with Thomas Jefferson University to distribute and commercialize a tumor-specific imaging agent used in the diagnosis of breast and prostate tumors.
February 5, 2008
B-K Medical, AMD debut prostate US tool
By AuntMinnie.com staff writers
Analogic subsidiary B-K Medical of Copenhagen, Denmark, and Advanced Medical Diagnostics of Waterloo, Belgium, have teamed up to introduce the Belgium-based firm HistoScanning tissue characterization technology for use in the prostate.
January 27, 2008
Studies outline techniques for ramping up MR in renal artery imaging
By Shalmali Pal
Nephrogenic systemic fibrosis (NSF) continues to puzzle the MR imaging community, but patients with renal disorders must still undergo imaging exams and MRI remains the best option for detecting and grading kidney disease. Two recent studies offer advanced techniques for MR angiography (MRA) and MRI in the renal arteries. In both cases, gadolinium-based agents were used successfully without any serious side effects. AuntMinnie.com takes a look at the studies and discusses the role of gadolinium-enhanced MRA in this patient population with the authors.
January 9, 2008
2008 01 09 13 30 29 706
CT for PE; how to assess kidney function: S-Cr or eGFR?
By Brian Casey
December 17, 2007
GFR no better than creatinine for predicting renal failure
By Eric Barnes
Kidney specialists may insist on calculating estimated glomerular filtration rates (eGFR) rather than serum creatinine (S-Cr) levels for assessing patients at risk of contrast-induced nephropathy (CIN). But the results of a six-year study from Virginia say one test is no better than the other for predicting renal failure.
December 17, 2007
2007 12 18 09 20 32 706
Previous Page
Page 67 of 93
Next Page